Agios Pharmaceuticals to Present New Research at the 12th International Congress of Inborn Errors of Metabolism Read more about Agios Pharmaceuticals to Present New Research at the 12th International Congress of Inborn Errors of Metabolism
Agios Pharmaceuticals Named 2014 World Economic Forum Technology Pioneer Read more about Agios Pharmaceuticals Named 2014 World Economic Forum Technology Pioneer
Agios Pharmaceuticals Closes Initial Public Offering Read more about Agios Pharmaceuticals Closes Initial Public Offering
Agios Pharmaceuticals Prices Initial Public Offering Read more about Agios Pharmaceuticals Prices Initial Public Offering
Agios Pharmaceuticals Closes $33 Million Series A Funding Read more about Agios Pharmaceuticals Closes $33 Million Series A Funding
Agios Pharmaceuticals Expands Into 21,000 SqFt Facility Read more about Agios Pharmaceuticals Expands Into 21,000 SqFt Facility
Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team Read more about Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team
Agios Pharmaceuticals Appoints Charles Sawyers, M.D.,to Scientific Advisory Board Read more about Agios Pharmaceuticals Appoints Charles Sawyers, M.D.,to Scientific Advisory Board
Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at AACR Read more about Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at AACR
Agios Pharmaceuticals Appoints David Schenkein, M.D., as CEO and Duncan Higgons as COO Read more about Agios Pharmaceuticals Appoints David Schenkein, M.D., as CEO and Duncan Higgons as COO